Vineti

Vineti

Vineti

The first commercial, cloud-based software platform to expand patient access to life-saving cell and gene therapies
Raised
$47.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$33,500,000
Venture capital (Series B) - 2018
GE Ventures Casdin Capital DFJ +4
$13,750,000
Venture capital (Series A) - 2017
GE Ventures DFJ LifeForce Capital +1
Team Size
1–10
Employees
MedCity News

Vineti, Deloitte Consulting partner software systems to improve cell, gene therapy access

$33,500,000 Venture capital (Series B)
FinSMEs

Vineti Closes $33.5M in Series B Funding

Funding Health Cloud
$13,750,000 Venture capital (Series A)
PE HUB

Vineti nets $13.75 mln Series A

Data leaks